Abstract:The analytical challenges of Pt determination by ICP-SFMS posed by different human tissues and fluids have been critically assessed. Investigated samples were (1) urine, (2) serum of cancer patients sampled during chemotherapy with carboplatin, (3) microdialysates (20 micro L sample volume) collected from tumor and non-tumor tissue, and, finally-for the first time-(4) human lung tissue to study background concentrations of inhaled platinum. Sample preparation involved microwave digestion and open vessel treatment or simple dilution (microdialysates). Depending on the sample preparation and introduction systems used (microconcentric nebulization, ultrasonic nebulization with and without membrane desolvation) excellent procedural detection limits (3s criterion) of 0.35 pg g(-1) for urine, 420 pg g(-1) for serum, 400 pg g(-1) for lung tissue and 13 pg g(-1) for microdialysates could be obtained. Ultratrace concentrations of 1-40 pg g(-1), and 1000-3000 pg g(-1) were measured in urine and human lung tissue, respectively, as typical for samples in environmental studies. Quantification was carried out by IDMS and standard addition in the case of urine samples. Internal standardization could not correct for non-spectral interferences in external calibration. In the serum and microdialysates of patients during chemotherapy with carboplatin, elevated Pt levels ranging between 0.01 and 10 micro g g(-1) were determined by external calibration ((195)Pt isotope). For all investigated samples spectral interferences could be excluded by following different strategies. High-resolution control measurements ((194)Pt, (195)Pt) were performed in the case of elevated Pt levels, i.e. for microdialysates and serum samples. An Hf/Pt ratio of 0.4 was determined in human lung samples. An HfO formation ratio of 0.2% was assessed for standard solutions at the present experimental conditions, revealing that the contribution of (179)Hf(16)O, (178)Hf(17)O, (177)Hf(18)O to the (195)Pt isotope signal used for quantification was not significant.

Speciation of platinum in blood plasma and urine by micelle-mediated extraction and graphite furnace atomic absorption spectrometry

Study of Solid Phase Extraction Prior to Spectrophotometric Determination of Platinum with N-(3,5-Dimethylphenyl)-N′-(4-Aminobenzenesulfonate)-Thiourea

Solid Phase Extraction and Spectrophotometric Determination of Platinum(Iv) with N-(3,5-Dihydroxyphenyl)-N '-(4-aminobenzenesulfonate)- Thiourea

Selective separation of palladium from synthetic highly active liquid waste by cloud point extraction using benzil mono-(2-pyridyl)hydrazone and Triton X-114

On-line Preconcentration and Separation of Platinum Using Thiourea Modified Silica Gel with Microwave Assisted Desorption for FAAS Determination

FAAS Determination of Platinum Using an On-Line Separation and Preconcentration System with a Polymelamine Dendrimer Immobilized Silica Gel

Preconcentration and determination of ultra-traces of platinum in human serum using the combined electrodeposition-electrothermal atomic absorption spectroscopy (ED-ETAAS) and chemometric method

Separation of Platinum(IV) from Pharmaceuticals using P-Methylphenyl Thiourea by Solvent Extraction: Separation from Palladium(II), Nickel (II)

Platinum determination by inductively coupled plasma-sector field mass spectrometry (ICP-SFMS) in different matrices relevant to human biomonitoring

Selective Solid-Phase Extraction and Separation of Trace Gold, Palladium and Platinum Using Activated Carbon Modified with Ethyl-3-(2-aminoethylamino)-2-chlorobut-2-enoate

Direct analysis of platinum in plasma and urine by electrothermal atomic absorption spectrophotometry

Determination of Platinum in Human Plasma by Microchip-based Nanoflow Injection and Inductively Coupled Plasma Mass Spectrometry

Determination of Platinum in Serum Samples by Inductively Coupled Plasma Mass Spectrometry with Microscale Flow Injection Based on a Heated Spray Chamber

Determination of Platinum, Palladium and Rhodium in Biological and Environmental Samples by Low Temperature Electrothermal Vaporization Inductively Coupled Plasma Atomic Emission Spectrometry with Diethyldithiocarbamate As Chemical Modifier

Electrothermal Vaporization Inductively Coupled Plasma Atomic Emission Spectrometry Determination of Gold, Palladium, and Platinum Using Chelating Resin YPA4 As Both Extractant and Chemical Modifier

Determination of Platinum and Palladium in Geological Samples by Inductively Coupled Plasma-Atomic Emission Spectrometry after Preconcentration with Immobilised Nanometric Titanium Dioxide

Cloud Point Extraction for Speciation of Chromium in Water Samples by Electrothermal Atomic Absorption Spectrometry

DETERMINATION OF PLATINUM IN CLINICAL SAMPLES

Magnetic Dual Task-Specific Polymeric Ionic Liquid Nanoparticles for Preconcentration and Determination of Gold, Palladium and Platinum Prior to Their Quantitation by Graphite Furnace AAS

Simultaneous Determination of Palladium and Platinum by On-Line Enrichment Followed by Rapid Column High Performance Liquid Chromatography